Use of neboglamine in the treatment of toxicodependency

Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CN...

Full description

Saved in:
Bibliographic Details
Main Authors CASELLI GIANFRANCO, GIORDANI ANTONIO, ROVATI LUCIO CLAUDIO, MAKOVEC FRANCESCO
Format Patent
LanguageEnglish
Published 04.09.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CNS sedatives such as opiates, barbiturates, benzodiazepines, alcohol, stimulants such as amphetamines and cocaine, and hallucinogens such as LSD, mescalin, cannabis (marijuana) or fencyclidine.
AbstractList Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CNS sedatives such as opiates, barbiturates, benzodiazepines, alcohol, stimulants such as amphetamines and cocaine, and hallucinogens such as LSD, mescalin, cannabis (marijuana) or fencyclidine.
Author GIORDANI ANTONIO
ROVATI LUCIO CLAUDIO
MAKOVEC FRANCESCO
CASELLI GIANFRANCO
Author_xml – fullname: CASELLI GIANFRANCO
– fullname: GIORDANI ANTONIO
– fullname: ROVATI LUCIO CLAUDIO
– fullname: MAKOVEC FRANCESCO
BookMark eNrjYmDJy89L5WQwDy1OVchPU8hLTcpPz0nMzcxLVcjMUyjJSFUoKUpNLMlNzSsByZfkV2Qm56ekFqTmpaTmJVfyMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL40GALI1MLQwtTJyNjIpQAAHi7L5E
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US8258185B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US8258185B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:01:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US8258185B23
Notes Application Number: US201113192071
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120904&DB=EPODOC&CC=US&NR=8258185B2
ParticipantIDs epo_espacenet_US8258185B2
PublicationCentury 2000
PublicationDate 20120904
PublicationDateYYYYMMDD 2012-09-04
PublicationDate_xml – month: 09
  year: 2012
  text: 20120904
  day: 04
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies GIORDANI ANTONIO
ROTTAPHARM S.P.A
ROVATI LUCIO CLAUDIO
MAKOVEC FRANCESCO
CASELLI GIANFRANCO
RelatedCompanies_xml – name: CASELLI GIANFRANCO
– name: MAKOVEC FRANCESCO
– name: ROVATI LUCIO CLAUDIO
– name: GIORDANI ANTONIO
– name: ROTTAPHARM S.P.A
Score 2.8552709
Snippet Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Use of neboglamine in the treatment of toxicodependency
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120904&DB=EPODOC&locale=&CC=US&NR=8258185B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB6WVdSbrorrixykt2LXttYeitAXi7AP3K3sbdk8Cj1sutiK-u-dxG71oreQgZBMmJkvyXwTgBtfeD53HW4yZlN1deOalHm2qaC3b1FOPaYIzqPx_TBznhbuogPFlguj64S-6-KIaFEM7b3W_nrzc4kV69zK6pYW2FU-pvMgNprTsSKC4qbHYZBMJ_EkMqIoyGbG-DnAg5AKTSF66x2FolWZ_eQlVKSUze-Ikh7C7hQHk_URdITswX60_XitB3uj5r0bm43pVcfgZZUgZU4kOgiEvGuUk0ISxG-kTRZX8rr8KBRP_ftvW_Z5AiRN5tHQxBks29Uus1k7V_sUurKU4gwIBtaB9ZCLFSrdQVRPLc4G3kqIu5wyTlkf-n8Oc_6P7AIOlNp01pRzCd369U1cYZit6bVW0BemE4O6
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT4MwEL4s0zjfdGqcP_tgeCMyByIPxAQYQR1scWD2RtZSEh4Gi2DU_94rMvRF35pe0rTX3N3X9r4rwJXBdSPR1ERmbETF1Y0mU6aPZAG9DYUmVGeC4OwHt16kPi60RQeyDRemrhP6XhdHRItiaO9V7a_XP5dYTp1bWV7TDLuKezc0Hak5HQsiKG66Y5nj2dSZ2pJtm9FcCp5NPAiJ0GSht97SRXFegZxeLEFKWf-OKO4ebM9wsLzahw7P-9CzNx-v9WHHb967sdmYXnkAelRyUqQkRweBkHeFcpLlBPEbaZPFhbwqPjLBU__-25Z9HgJxx6HtyTiDuF1tHM3buY6OoJsXOT8GgoF1qNylfIlKVxHVUyVhQ33J-U1KWULZAAZ_DnPyj-wSel7oT-LJQ_B0CrtChXUGlXoG3er1jZ9jyK3oRa2sL_eFhqc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+neboglamine+in+the+treatment+of+toxicodependency&rft.inventor=CASELLI+GIANFRANCO&rft.inventor=GIORDANI+ANTONIO&rft.inventor=ROVATI+LUCIO+CLAUDIO&rft.inventor=MAKOVEC+FRANCESCO&rft.date=2012-09-04&rft.externalDBID=B2&rft.externalDocID=US8258185B2